Here’s a Look at SEVMIA, the First Generic Weight-Loss Injection Approved by Health Canada

Here’s a look at SEVMIA, the first generic weight-loss injection approved by Health Canada

What to know SEVMIA is a generic version of semaglutide, the active ingredient in Wegovy, and is approved for chronic weight management in Canada. The drug is a once-weekly injection for patients aged 12 and older, to be used alongside a reduced-calorie diet and increased physical activity. SEVMIA should not be combined with Ozempic or any other semaglutide product, and can cause side effects such as nausea, headache, and digestive issues. Pati…